本页面由Tiger Trade Technology Pte. Ltd.提供服务

ArTara Therapeutics, Inc.

3.84
-0.0100-0.26%
成交量:10.94万
成交额:41.39万
市值:2.27亿
市盈率:-2.84
高:3.89
开:3.84
低:3.72
收:3.85
52周最高:7.82
52周最低:3.02
股本:5,909.55万
流通股本:5,741.44万
量比:0.71
换手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):-1.3535
每股收益(LYR):-1.3409
净资产收益率:-45.80%
总资产收益率:-28.82%
市净率:1.41
市盈率(LYR):-2.86

数据加载中...

2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/05/20

SEC问询函

Form CORRESP - Correspondence
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities